» Articles » PMID: 23732084

The Role of Renal Proximal Tubule P450 Enzymes in Chloroform-induced Nephrotoxicity: Utility of Renal Specific P450 Reductase Knockout Mouse Models

Overview
Specialties Pharmacology
Toxicology
Date 2013 Jun 5
PMID 23732084
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

The kidney is a primary target for numerous toxic compounds. Cytochrome P450 enzymes (P450) are responsible for the metabolic activation of various chemical compounds, and in the kidney are predominantly expressed in proximal tubules. The aim of this study was to test the hypothesis that renal proximal tubular P450s are critical for nephrotoxicity caused by chemicals such as chloroform. We developed two new mouse models, one having proximal tubule-specific deletion of the cytochrome P450 reductase (Cpr) gene (the enzyme required for all microsomal P450 activities), designated proximal tubule-Cpr-null (PTCN), and the other having proximal tubule-specific rescue of CPR activity with the global suppression of CPR activity in all extra-proximal tubular tissues, designated extra-proximal tubule-Cpr-low (XPT-CL). The PTCN, XPT-CL, Cpr-low (CL), and wild-type (WT) mice were treated with a single oral dose of chloroform at 200mg/kg. Blood, liver and kidney samples were obtained at 24h after the treatment. Renal toxicity was assessed by measuring BUN and creatinine levels, and by pathological examination. The blood and tissue levels of chloroform were determined. The severity of toxicity was less in PTCN and CL mice, compared with that of WT and XPT-CL mice. There were no significant differences in chloroform levels in the blood, liver, or kidney, between PTCN and WT mice, or between XPT-CL and CL mice. These findings indicate that local P450-dependent activities play an important role in the nephrotoxicity induced by chloroform. Our results also demonstrate the usefulness of these novel mouse models for studies of chemical-induced kidney toxicity.

Citing Articles

Acute and chronic toxicity studies on ethanolic leaf extracts of and in Swiss albino mice.

Chandrashekar R, Rai M, Kalal B Int J Biochem Mol Biol. 2022; 13(4):40-48.

PMID: 36188728 PMC: 9520248.


Assessing cytochrome P450 function using genetically engineered mouse models.

Hannon S, Ding X Adv Pharmacol. 2022; 95:253-284.

PMID: 35953157 PMC: 10544722. DOI: 10.1016/bs.apha.2022.05.008.


Proximal Tubular Vacuolization and Hypersensitivity to Drug-Induced Nephrotoxicity in Male Mice With Decreased Expression of the NADPH-Cytochrome P450 Reductase.

Ding L, Li L, Liu S, Bao X, Dickman K, Sell S Toxicol Sci. 2019; 173(2):362-372.

PMID: 31693140 PMC: 8000068. DOI: 10.1093/toxsci/kfz225.


Advances in predictive in vitro models of drug-induced nephrotoxicity.

Soo J, Jansen J, Masereeuw R, Little M Nat Rev Nephrol. 2018; 14(6):378-393.

PMID: 29626199 PMC: 6013592. DOI: 10.1038/s41581-018-0003-9.

References
1.
Gu J, Weng Y, Zhang Q, Cui H, Behr M, Wu L . Liver-specific deletion of the NADPH-cytochrome P450 reductase gene: impact on plasma cholesterol homeostasis and the function and regulation of microsomal cytochrome P450 and heme oxygenase. J Biol Chem. 2003; 278(28):25895-901. DOI: 10.1074/jbc.M303125200. View

2.
Fang C, Behr M, Xie F, Lu S, Doret M, Luo H . Mechanism of chloroform-induced renal toxicity: non-involvement of hepatic cytochrome P450-dependent metabolism. Toxicol Appl Pharmacol. 2007; 227(1):48-55. PMC: 2274901. DOI: 10.1016/j.taap.2007.10.014. View

3.
Zhang Q, Fang C, Zhang J, Dunbar D, Kaminsky L, Ding X . An intestinal epithelium-specific cytochrome P450 (P450) reductase-knockout mouse model: direct evidence for a role of intestinal p450s in first-pass clearance of oral nifedipine. Drug Metab Dispos. 2008; 37(3):651-7. PMC: 2645477. DOI: 10.1124/dmd.108.025429. View

4.
Ding Y, Sigmund C . Androgen-dependent regulation of human angiotensinogen expression in KAP-hAGT transgenic mice. Am J Physiol Renal Physiol. 2001; 280(1):F54-60. DOI: 10.1152/ajprenal.2001.280.1.F54. View

5.
Fang C, Gu J, Xie F, Behr M, Yang W, Abel E . Deletion of the NADPH-cytochrome P450 reductase gene in cardiomyocytes does not protect mice against doxorubicin-mediated acute cardiac toxicity. Drug Metab Dispos. 2008; 36(8):1722-8. PMC: 2575052. DOI: 10.1124/dmd.108.021881. View